Transmissible spongiform encephalopathies (TSEs)

• TGA approach to minimising the risk of exposure to Transmissible Spongiform Encephalopathies (TSEs) through medicines and medical devices
  <http://www.tga.gov.au/docs/html/tsepolicy.htm>
• Supplementary requirements for therapeutic goods for minimising the risk of transmitting Transmissible Spongiform Encephalopathies (TSEs)
  <http://www.tga.gov.au/docs/html/tsesupp.htm>
• Transmissible Spongiform Encephalopathies (TSEs) questionnaire for sponsors
  <http://www.tga.gov.au/docs/html/tseq.htm>
• Requirements for the assessment of medical devices containing animal material, with particular regard to the minimisation of risks relating to transmitting Transmissible Spongiform Encephalopathies (TSEs) (Australian medical devices guidance document)
  <http://www.tga.gov.au/docs/html/devguid14.htm>
• Questions and answers on BSE risk associated with the use of materials of bovine origin during the manufacture of vaccines
  <http://www.tga.gov.au/docs/html/bsefaq.htm>
• Pre-clearance application form for animal-derived ingredients
  <http://www.tga.gov.au/cm/forms/animder.htm>